T78.01XD Anaphylactic reaction due to peanuts, subsequent encounter

Name of the Condition

• Anaphylactic reaction due to peanuts, subsequent encounter (ICD-10 Code: T78.01XD)

Summary

This code is used to document a subsequent encounter for an anaphylactic reaction specifically triggered by peanuts. Anaphylaxis is a severe, potentially life-threatening allergic reaction that requires immediate medical attention. The code applies when the reaction is directly linked to peanut exposure and meets clinical criteria for anaphylaxis, and the encounter occurs during the recovery phase after the initial event.

Causes

Anaphylactic reactions due to peanuts occur when the immune system overreacts to proteins in peanuts. The reaction is mediated by immunoglobulin E (IgE) antibodies, which release histamine and other chemicals, leading to rapid onset of symptoms. Even trace amounts of peanuts can trigger a reaction in sensitive individuals.

Risk Factors

• Previous history of peanut allergy or anaphylaxis
• Family history of allergic conditions
• Asthma or other atopic diseases
• Exposure to peanuts or peanut-containing products
• Delayed administration of epinephrine during prior reactions

Symptoms

• Rapid onset of hives, itching, or swelling (especially of the lips, tongue, or throat)
• Difficulty breathing, wheezing, or stridor
• Drop in blood pressure (hypotension) or dizziness
• Nausea, vomiting, or abdominal cramps
• Loss of consciousness or confusion

Diagnosis

Diagnosis is based on clinical presentation and patient history. Key criteria include acute onset of symptoms, involvement of the skin or mucosal tissue, respiratory compromise, reduced blood pressure, or gastrointestinal symptoms. Laboratory tests (e.g., specific IgE) may support the diagnosis, but clinical judgment is primary.

Treatment Options

• Immediate administration of epinephrine (first-line treatment)
• Antihistamines or corticosteroids to manage symptoms
• Oxygen therapy for respiratory distress
• Intravenous fluids for hypotension
• Monitoring in a medical facility for recurrence

Prognosis and Follow-Up

Most patients recover fully with prompt treatment. Follow-up care includes allergist referral, avoidance education, and prescription of an epinephrine auto-injector. Long-term prognosis depends on adherence to avoidance strategies and preparedness for future reactions.

Complications

• Respiratory failure or arrest
• Cardiovascular collapse
• Asphyxiation from airway swelling
• Delayed biphasic reactions (recurrence of symptoms hours later)

Lifestyle & Prevention

• Strict avoidance of peanuts and peanut-containing products
• Reading food labels carefully
• Informing restaurants and caregivers of the allergy
• Carrying an epinephrine auto-injector at all times
• Wearing medical identification jewelry

When to Seek Professional Help

Seek immediate medical attention if symptoms of anaphylaxis occur, such as difficulty breathing, swelling of the throat, or dizziness. Follow-up with an allergist is recommended after any reaction to establish a management plan.

Tips for Medical Coders

Document the specific trigger (peanuts) and confirm the encounter is a subsequent one (not the initial event). Ensure clinical notes support the diagnosis and encounter type. The "subsequent encounter" modifier (XD) indicates the patient is in the recovery phase, not the acute phase of the reaction.